acetylglucosamine has been researched along with Myeloproliferative Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elabd, M; Freund, P; Gouilleux, F; Groner, B; Hager, M; Han, X; Kerenyi, MA; Krämer, OH; Moriggl, R; Pham, HTT; Sexl, V; Valent, P; Wagner, T; Wingelhofer, B | 1 |
1 other study(ies) available for acetylglucosamine and Myeloproliferative Disorders
| Article | Year |
|---|---|
O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies.
Topics: Acetylglucosamine; Animals; Cell Line; Cell Transformation, Neoplastic; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Glycosylation; Humans; Interleukin-3; Lymphoid Tissue; Male; Mice; Mutagenesis, Site-Directed; Myeloproliferative Disorders; Phosphorylation; Phosphotyrosine; Protein Processing, Post-Translational; Radiation Chimera; Recombinant Fusion Proteins; Signal Transduction; STAT5 Transcription Factor; T-Lymphocytes; Threonine; Transcriptional Activation; Tumor Suppressor Proteins | 2017 |